Mobilized versus non-mobilized peripheral stem cell transplantation after high dose therapy for low grade nonhodgkin lymphoma: Effect on failure-free survival

Cancer Research, Therapy and Control

Volumn 5, Issue 2, 1998, Pages 113-119

  Kessinger, A ^a,c   Bierman, P J ^a   Cowles, M K ^b   Anderson, J R ^b   Armitage, J O ^a   Bishop, M R ^a   Vose, J M ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c UNIVERSITY OF NEBRASKA AT OMAHA   (United States)

Author keywords

Mobilization; Progenitor; Relapse free survival; Tumor cell

Indexed keywords

ERYTHROPOIETIN; HEMOPOIETIC GROWTH FACTOR; MILODISTIM; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ADULT; ARTICLE; AUTOGRAFT; BONE MARROW SUPPRESSION; CANCER GRADING; CANCER SURVIVAL; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; METASTASIS; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL;

EID: 0031738968     PISSN: 10640525     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Brugger, W., Bross, K. J., Glatt, M., Weber, F., Mertelsmann, R. and Kanz, L. (1994). Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors. Blood, 83, 636-640.
2. Gribben, J. G., Freedman, A. S. and Neuberg, D. et al. (1991). Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma, New Eng. J. Med., 22, 1525-1533.
3. Hohaus, S., Goldschmidt, H., Ehrhardt, R. and Haas, R. (1993). Successful autografting following myeloablative conditioning therapy with blood stem cells mobilized by chemotherapy plus rhG-CSF. Exp. Hematol., 21, 508-514.
4. Kessinger, A., Armitage, J. O., Landmark, J. D., Smith, D. M. and Weisenburger, D. D. (1988). Autologous peripheral hematopoietic stem cell transplantation restores hematopoietic function following marrow ablative therapy. Blood, 71, 723-727.
5. Maraud, X., Fermand, J. P. and Brouet, J. C. (1994). Myeloma cell contamination of peripheral blood stem cell grafts in patients with multiple myeloma treated by high-dose therapy. Bone Marrow Transplant., 14, 47-50.
6. Negrin, R. S. and Pesando, J. (1994). Detection of tumor cells in purged bone marrow and peripheral-blood mononuclear cells by polymerase chain reaction amplification of bcl-2 translocations. J. Clin. Oncol., 12, 1012-1027.
7. Passos-Coelho, J. L., Ross, A. A., Moss, T. J., Davis, J. M., Huelskamp, A.-M., Noga, S. J., Davidson, N. E. and Kennedy, M. J. (1995). Absence of breast cancer cells in a single-day peripheral blood progenitor cell collection after priming with cyclophosphamide and granulocyte-macrophage colony-stimulating factor. Blood, 85, 1138-1143.
8. Vora, A. I., Toh, C. H., Peel, J. and Greaves, M. (1994). Use of granulocyte colony-stimulating factor (G-CSF) for mobilizing peripheral blood stem cells: risk of mobilizing clonal myeloma cells in patients with bone marrow infiltration. Br. J. Haematol., 86, 180-182.